Close Menu

NEW YORK (GenomeWeb) – GeneNews reported today that its third quarter revenues fell 51 percent as the company is changing how it bills for its ColonSentry colorectal cancer blood test and other diagnostics.

For the three-month period ended Sept. 30, GeneNews' revenues fell to $54,290 from $111,103 in the year-ago quarter. In a statement, GeneNews Chairman and CEO James Howard-Tripp called the revenue results "disappointing and reflective of the changes we are currently making in our billing processes."

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.